Galderma Reaffirms Its Leadership in Dermatology With Extensive Presence at EADV 2024
Late-breaking presentations will reveal important new data from the phase III OLYMPIA and ARCADIA trials, including durability and long-term efficacy of nemolizumab in prurigo nodularis and atopic dermatitis, respectively Galderma will also host a symposium and industry hub session for healthcare professionals on the impact of itch in prurigo nodularis and atopic dermatitis to further educate on these serious conditions Three additional industry hub sessions will explore Galderma’s latest research from across the full dermatology spectrum, including on sensitive skin - featuring updates from the Global Sensitive Skincare Faculty - as well as on new skin quality and holistic acne management tools In total, Galderma will present 30 abstracts at the congress, reinforcing its leadership and commitment to advancing dermatology for every skin story
Galderma (SWX:GALD), the pure-play dermatology category leader, announced today it will be showcasing updates from across its industry-leading dermatology portfolio at the 33rd European Academy of Dermatology and Venereology (EADV) congress taking place in Amsterdam, September 25-28, 2024, reinforcing its commitment to advancing dermatology for every skin story. In addition to presenting 30 abstracts with data on prurigo nodularis, atopic dermatitis, sensitive skin and acne, Galderma will host a series of events dedicated to addressing the real needs of patients and connecting with the dermatology community, including a symposium and several industry hub sessions and Meet the Experts sessions at the Galderma booth.
“EADV is such an important opportunity for us to connect with the community so we can share updates and facilitate discussions that will accelerate science in dermatology. This year, our congress program, including the presentation of new data on nemolizumab in both prurigo nodularis and atopic dermatitis, underscores our leading position in the field and highlights the power of our unique, integrated dermatology strategy.”
BALDO SCASSELLATI SFORZOLINI, M.D., Ph.D. GLOBAL HEAD OF R&D GALDERMA
|
Deep diving on nemolizumab data in prurigo nodularis and atopic dermatitis
Galderma will be presenting nine abstracts on its monoclonal antibody nemolizumab. These include three late-breaking presentations, one on its durability in prurigo nodularis on Wednesday 25 September at 2:15 – 2:30 pm CET and two on its long-term efficacy and transcriptomics data in atopic dermatitis on Wednesday 25 September at 3 – 3:15 pm CET and 4:30 – 4:45 pm CET, respectively. Additional data will be presented on nemolizumab’s speed of onset in prurigo nodularis, immunogenicity profile, and dosing.
The symposium and industry hub session for healthcare professionals will also explore the unmet needs in prurigo nodularis and atopic dermatitis, including the impact of itch, reinforcing Galderma’s ongoing commitment to addressing the most burdensome symptom of both diseases.1,2 The industry hub session, titled “From neglect to necessity: Elevating itch monitoring in atopic dermatitis and prurigo nodularis” will be held on Thursday, September 26, 4:15-5:00 PM CET (Hub 1.09) and hosted by Prof. Jonathan Silverberg, Prof. Shawn Kwatra, and Prof. Martin Metz. The symposium, titled "Shifting the paradigm in the management of atopic dermatitis and prurigo nodularis: Expert insights into the unmet need for itch control” will take place on Friday, September 27, 1:00-2:00 PM CET (Room 7.2). It will be chaired by Prof. Diamant Thaçi, featuring guest speakers Prof. Sonja Ständer, Dr. Sarina Elmariah, and Dr. Andrew Pink.
Showcasing best-in-class science across the full spectrum of dermatology
Galderma will also host an event to share updates from its Global Sensitive Skincare Faculty (GSSF), a first-of-its-kind global community of experts dedicated to creating a better life for people with sensitive skin. Since its inception in 2022, the GSSF has promoted the advancement of sensitive skin science, establishing sensitive skin as a distinct and complex condition. During this session, chaired by Prof. Giovanni Pellacani, experts will share data and trends from the most extensive global epidemiological survey ever conducted - with more than 16,000 subjects - and discuss how this research can be applied in clinical practice. The industry hub session titled “Decoding sensitive skin: Revolutionary and unexpected findings from the broadest worldwide profiling survey” will take place on Thursday, September 26, 2:15-3:00 PM CET (Hub 1.07).
An industry hub session titled “New Skin Quality Assessment Scale – Looking Beyond the Disease” will delve into a new tool Galderma has developed to accurately assess and improve skin quality. The event will take place on Thursday, September 26, 3:15-4:00 PM CET (Hub 1.08).
Finally, attendees interested in acne management can learn more during the dedicated industry hub session “OneAcne: A holistic management approach to improve treatment outcomes in acne, acne sequelae and skin quality”, which will be taking place on Friday, September 27, 3:15-4:00 PM CET (Hub 1.14). Participants will be invited to explore Galderma’s integrated approach in acne management and its unique portfolio of tools from across the dermatology spectrum combined to manage the individual needs of acne patients, from acne prone skin, through breakouts, to scarring.
More details on Galderma’s scientific presentations at EADV can be found here.
About Galderma
Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ—the skin—meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com
References:
- Pereira MP, et al. Prurigo nodularis: a physician survey to evaluate current perceptions of its classification, clinical experience and unmet need. J Eur Acad Dermatol Venereol. 2018;32(12):2224-2229. doi:10.1111/jdv.15107
- Silverberg JI, et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018;121(3):340-347. doi:10.1016/j.anai.2018.07.006
View source version on businesswire.com: https://www.businesswire.com/news/home/20240916437749/en/
Contacts
For further information:
For further information:
Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50
Sébastien Cros
Corporate Communications Director
sebastien.cros@galderma.com
+41 79 529 59 85
Emil Ivanov
Head of Strategy, Investor Relations, and ESG
emil.ivanov@galderma.com
+41 21 642 78 12
Jessica Cohen
Investor Relations and Strategy Director
jessica.cohen@galderma.com
+41 21 642 76 43
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Ancient Grounds to an Intelligent Future: The 1st International Humanoid Olympiad Launches in Olympia, Greece29.5.2025 00:47:00 CEST | Press release
This year, Olympia, Greece, the birthplace of the Olympic Games, welcomes the inaugural International Humanoid Olympiad. From August 29th to September 2nd, at the International Olympic Academy in Olympia, humanoid robots will participate in demonstrations and Olympic-inspired games, showcasing their dexterity and intelligence, while global leaders in robotics and AI will share insights through expert talks and workshops. Blending millennia-old values, ethos, and ideals with a bold vision for the future, the event will spotlight how human creativity and robotics are shaping the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250528788233/en/ This global gathering brings together state-of-the-art humanoid robots in spectacular showcases designed to captivate audiences of all ages and backgrounds while their creators, researchers, engineers, students, and visionaries are pushing the boundaries of what intelligent machine
Mary Kay Inc. Awards 10 Grants to Young Innovators at 2025 Regeneron International Science and Engineering Fair28.5.2025 22:29:00 CEST | Press release
Mary Kay Inc., a global advocate for furthering young women’s education and encouraging youth to follow their STEM dreams, returned for a second year as a Special Awards Organization at the Regeneron International Science and Engineering Fair (Regeneron ISEF) in Columbus, Ohio. Ten grants totaling nearly $10,000 were awarded to standout high school-aged students excelling in innovative projects spanning topics from finding cures for cancers affecting women to sustainable packaging innovation and protecting our planet’s most valuable resources. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250528325390/en/ Kristin Dasaro, Director, Package Engineering and Sustainability at Mary Kay, greets Brazilian cancer researcher, Carolina de Araujo Pereira da Silva, who received back-to-back awards from Mary Kay for innovative findings in the malignancy of tumors. (Photo Credit: Mary Kay Inc.) Each year, the event convenes nearly 2,000
Duravant Completes Acquisition of Pattyn28.5.2025 19:44:00 CEST | Press release
Automation Equipment Leader Duravant expands Packaging Group with Acquisition of Pattyn Duravant LLC (“Duravant”), a global engineered equipment and automation solutions provider to the protein processing, food sorting and handling, packaging, and material handling sectors, announced the completion of its acquisition of the Pattyn Group BV (“Pattyn”), a leading manufacturer of packaging automation systems headquartered in Bruges, Belgium. The transaction was first announced on February 7, 2025, and was completed today. With over 70 years of expertise, Pattyn is a trusted partner for companies looking to automate bulk packaging operations in industries ranging from food and ingredients to non-food applications. Pattyn has been a world-renowned brand specializing in bag-in-box packaging technology, and their comprehensive end-of-line solutions span the entire packaging process from case erecting and bag inserting to weigh filling, bag and case closing, and palletizing. “We are extremely
Rimini Street Appoints Vijay Kumar as EVP and Chief Operating Officer28.5.2025 18:00:00 CEST | Press release
Seasoned business and IT executive leader to drive operational efficiency, scaling, increased profitability and accelerated growth of the business Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, management and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced the appointment of Vijay Kumar as executive vice president (EVP) and chief operating officer (COO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250528704180/en/ Rimini Street Appoints Vijay Kumar as EVP and Chief Operating Officer In this role, Mr. Kumar leads product management, service strategy and offerings for Rimini Street’s “Support, Optimize and Innovate” solutions and oversees Rimini Street’s Global Capability Centers (GCC). Mr. Kumar also drives operational efficiency and innovation of the portfolio to increase profitability and accelerate t
Cargill Earns #1 Global Ranking for Removing Trans Fats From Edible Oils Portfolio28.5.2025 17:12:00 CEST | Press release
International nutrition foundation recognizes Cargill’s global leadership on industrially produced trans-fatty acid removal Cargill earned the top spot on the inaugural Edible Oil Supplier Index 2025, published by global nonprofit Access to Nutrition initiative (ATNi). The ranking recognizes the company’s leadership in removing industrially produced trans-fatty acids* (iTFAs) from its entire edible oils portfolio, even in markets with no regulatory mandate. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250528074187/en/ Cargill earned the top spot on the inaugural Edible Oil Supplier Index 2025, published by global nonprofit Access to Nutrition initiative (ATNi) Cargill’s leadership in this space has made a tangible difference for customers and consumers around the world. Chantilly, a cherished brand in Mexico known for its bakery, pastry and confectionery products, is a standout example. The company credits Cargill as a key
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom